| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790258 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Differential gene expression and protein activity associated with mTOR signaling is observed among bladder cancer cell lines stratified into basal, luminal, and nontype subtypes. Urothelial carcinomas characterized by high baseline Akt Ser-473 phosphorylation may be best suited for targeted mTOR therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Andrew M. Ph.D., Manando M.D., Ph.D., Kazufumi M.D., Goutam B.S., Donna E. M.D., Ph.D.,